Tolerability and antidepressive effect of brofaromine, a short-acting reversible MAO inhibitor — an open study
- 1 May 1991
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 1 (2) , 177-180
- https://doi.org/10.1016/0924-977x(91)90721-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical and Laboratory Studies with Selective Monoamine-Oxidase-Inhibiting DrugsPublished by S. Karger AG ,2015
- Management of Monoamine Oxidase Inhibitor-Associated Insomnia with TrazodoneJournal of Clinical Psychopharmacology, 1989
- Oral Tyramine Pressor Test and the Safety of Monoamine Oxidase Inhibitor DrugsJournal of Clinical Psychopharmacology, 1988
- Results of an Open Clinical Trial of Brofaromine (CGP 11 305 A), a Competitive, Selective, and Short-Acting Inhibitor of MAO-A in Major Endogenous DepressionPharmacopsychiatry, 1987
- The Present Status of Monoamine Oxidase InhibitorsThe British Journal of Psychiatry, 1985
- Adverse Reactions to Monoamine Oxidase Inhibitors. Part II. Treatment Correlates and Clinical ManagementJournal of Clinical Psychopharmacology, 1985
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960